Table 2 Patterns of glycaemic management among diabetic patients at JUSH, November 2009
Glycemic managements | Type 1 DM | Type 2 DM | Total | |||
|---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Initial management | ||||||
MNT | 4 | 3.4 | 14 | 6.6 | 18 | 5.5 |
OGLA | 15 | 12.8 | 188 | 88.7 | 203 | 61.7 |
Insulin | 98 | 83.8 | 9 | 4.2 | 107 | 32.5 |
Herbal treatment | 0 | 0.0 | 1 | 0.5 | 1 | 0.3 |
Current management | ||||||
MNT alone | 0 | 0 | 1 | 0.5 | 1 | 0.3 |
Insulin alone | 109 | 93.2 | 61 | 28.8 | 170 | 51.7 |
Insulin and OGLA | 7 | 6.0 | 6 | 2.8 | 13 | 4.0 |
Single OGLA | 0 | 0.0 | 69 | 32.5 | 69 | 21.0 |
Combination OGLA | 1 | 0.8 | 75 | 35.4 | 76 | 23.1 |
Initiation of pharmacologic treatment | ||||||
At the time of diagnosis | 112 | 95.7 | 184 | 86.8 | 296 | 90.0 |
Later on | 5 | 4.3 | 28 | 13.2 | 33 | 10.0 |
FBS (mg/dl) | ||||||
< 70 | 0 | 0.0 | 2 | 1.0 | 2 | 0.6 |
70-130 | 24 | 22.4 | 58 | 28.3 | 82 | 26.3 |
> 130 | 83 | 77.6 | 145 | 70.7 | 228 | 73.1 |
Doses of drugs (mean ± SD) | ||||||
Insuline - IU | 52.4 ± 20.1 | 45.0 ± 15.8 | 49.7 ± 19.0 | |||
Glibenclamide - mg/dl | 20.0 ± 0 | 15.2 ± 6.5 | 15.3 ± 6.5 | |||
Metformine- mg/dl | 625.0 ± 231.5 | 882.0 ± 406.1 | 860.8 ± 400.1 | |||